Menu

• Ask a Health Expert about CYTOGENETIC ABNORMALITY
• Post Your Side Effect related to CYTOGENETIC ABNORMALITY
• CYTOGENETIC ABNORMALITY and FDA Warnings
• CYTOGENETIC ABNORMALITY in Patients Wiki
• Report CYTOGENETIC ABNORMALITY in Drug Side Effect Survey

CYTOGENETIC ABNORMALITY side effect

What is CYTOGENETIC ABNORMALITY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Valproic Side Effects Report #5675027-2
Consumer or non-health professional from UNITED STATES reported VALPROIC ACID problem on Mar 12, 2008. Female patient, child 2 years of age, was diagnosed with petit mal epilepsy and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemoid reaction, . VALPROIC ACID dosage: 675 MG/DAY (33 MG/KG/DAY. During the same period patient was treated with ZONISAMIDE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5625515-X
FLUDARABINE problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . FLUDARABINE dosage: 250MG/M2 DAY1-3 Q-28D. During the same period patient was treated with MITOXANTRONE, ZEVALIN. Patient recovered.

Revlimid Side Effects Report #5635780-0
Health Professional from FRANCE reported REVLIMID problem on Feb 13, 2008. Female patient, 50 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, lung infection, . REVLIMID dosage: 5 MG, DAILY; ORAL, 10 MG, DAILY X3 WEEKS EVERY MONTH; ORAL. Patient died on 12/01/2006.

Vincristine Side Effects Report #5608506-4
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 52 years of age, was diagnosed with lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.


Vincristine Side Effects Report #5608507-6
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Male patient, 47 years of age, was diagnosed with diffuse large b-cell lymphoma stage iii and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.

Vincristine Side Effects Report #5608509-X
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma stage iii and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.

Vincristine Side Effects Report #5608515-5
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma stage iv, b-lymphocyte count increased and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, granulocytes abnormal, haematopoietic stem cell mobilisation, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Vincristine Side Effects Report #5608528-3
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 48 years of age, was diagnosed with lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.

Vincristine Side Effects Report #5608529-5
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Female patient, 47 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.


Rebif Side Effects Report #5481987-5
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . REBIF dosage: unknown. Patient died.

Zyprexa Side Effects Report #5406822-2
Physician from AUSTRALIA reported ZYPREXA problem on July 24, 2007. Female patient, weighting 0.68 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, failure to thrive, . ZYPREXA dosage: 5 MG, DAILY (1/D). During the same period patient was treated with ELEVIT, TEMAZE. Patient recovered.

Cyclophosphamide Side Effects Report #5400582-7
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.

Cyclophosphamide Side Effects Report #5400582-7
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.

Reyataz Side Effects Report #5755562-9
REYATAZ problem was reported by a Pharmacist from UNITED STATES on May 28, 2008. Female patient, 37 years of age, was treated with REYATAZ. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, pregnancy, . REYATAZ dosage: unknown. During the same period patient was treated with TRUVADA, NORVIR. Patient recovered.


Ritonavir Side Effects Report #5759802-1
Consumer or non-health professional from UNITED STATES reported RITONAVIR SOFT GELATIN CAPSULES problem on May 28, 2008. Female patient, 37 years of age, was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, TRUVADA. Patient recovered.

Zevalin Side Effects Report #5764135-3
ZEVALIN problem was reported by a Health Professional from UNITED STATES on May 23, 2008. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, non-hodgkin's lymphoma recurrent, refractory anaemia with an excess of blasts, refractory anaemia with ringed sideroblasts, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN, FLUDARABINE PHOSPHATE, MITOXANTRONE. Patient recovered.

Bexxar Side Effects Report #5778127-1
Health Professional from UNITED STATES reported BEXXAR problem on June 18, 2008. Male patient, weighting 149.0 lb, was treated with BEXXAR. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, thrombocytopenia, . BEXXAR dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.

Etoposide Side Effects Report #5781343-6
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, BUSULFAN, NEUPOGEN, DAUNORUBICIN, FLUDARABINE, MELPHALAN. Patient recovered.

Etoposide Side Effects Report #5781348-5
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 16, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, LEUKINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.


Etoposide Side Effects Report #5797753-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemia recurrent, myelodysplastic syndrome, . ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with MITOXANTRONE, CYTARABINE, DAUNORUBICIN, MELPHALAN. Patient died.

Etoposide Side Effects Report #5797754-9
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 19, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, . ETOPOSIDE dosage: 100 MG/M**2; DAILY. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.

Briplatin Side Effects Report #5753357-3
BRIPLATIN problem was reported by a Health Professional from JAPAN on May 26, 2008. Female patient, child 9 years of age, was diagnosed with desmoplastic small round cell tumour and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, venoocclusive liver disease, . BRIPLATIN dosage: unknown. During the same period patient was treated with ENDOXAN, ONCOVIN, PIRARUBICIN. Patient recovered.

Velcade Side Effects Report #5710855-6
Physician from JAPAN reported VELCADE problem on Apr 04, 2008. Female patient, 66 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VELCADE dosage: unknown. Patient recovered.

Vincristine Side Effects Report #5712899-7
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 52 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712902-4
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, erythropoiesis abnormal, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712908-5
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712911-5
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712940-1
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 56 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713367-9
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713376-X
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 35 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713385-0
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 33 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713409-0
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713410-7
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 44 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713414-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713419-3
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713420-X
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 42 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713421-1
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 57 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETPOSIDE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.

Vincristine Side Effects Report #5713422-3
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 57 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713450-8
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 22 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713472-7
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713491-0
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 50 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713494-6
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 25 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713495-8
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 34 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713496-X
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 38 years of age, was diagnosed with plasmacytoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713509-5
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713510-1
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713511-3
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, polymerase chain reaction, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713512-5
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 55 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713513-7
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 20 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713537-X
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 44 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713545-9
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 26 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.